Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

completed125%
terminated125%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
unknownnot_applicable

The Asia Primary Tube Versus Trab (TVT) Study

NCT03274024
completednot_applicable

Tube Versus Trabeculectomy (TVT) Study

NCT00306852
unknownnot_applicable

Trabeculectomy Versus Canaloplasty to Treat Glaucoma

NCT00854256
terminatedphase_4

A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy

NCT00597181

Clinical Trials (4)

Showing 4 of 4 trials
NCT03274024Not Applicable

The Asia Primary Tube Versus Trab (TVT) Study

Unknown
NCT00306852Not Applicable

Tube Versus Trabeculectomy (TVT) Study

Completed
NCT00854256Not Applicable

Trabeculectomy Versus Canaloplasty to Treat Glaucoma

Unknown
NCT00597181Phase 4

A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy

Terminated

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4